MPN Cancer Connection partners with PAN Foundation on Medication Assistance Programs for MPN Patients

Risk of Myeloid Blood Cancers are increased in relatives of patients
August 7, 2018
Dr. Verstovsek on Benefit of Ruxolitinib in Polycythemia Vera
Benefit of Ruxolitinib Treatment in Polycythemia Vera by Dr. Verstovsek
February 1, 2019

MPN Cancer Connection partners with PAN Foundation on Medication Assistance Programs for MPN Patients

PAN Foundation provides patient assistance program for medications for MPN patients

by David Wallace

MPN Cancer Connection is very pleased to announce a new partnership with the PAN Foundation.  Myeloproliferative Neoplasm (MPN) patients may be eligible for $8,500 per year (or more if a 2nd grant is needed/approved) in assistance assuming you meet the eligibility criteria which are very reasonable.

PAN Foundation Patient Assistance programs for MPN patients

 

 

The status is presently open and you can apply online or call 1-866-316-7263.  Their coverage for MPN patients is very comprehensive.  A few of the drugs include:

  • Jakafi
  • Pegasys (peginterferon alfa-2a)
  • Hydrea
  • Intron A (interferon alfa-2b)
  • Anagrelide Hcl
  • Prednisone
  • Busulfun
  • Danazol

MPN Patient Assistance programs

Please check out the PAN Foundation website for a complete list.

The Patient Access Network (PAN) Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications.  Since its founding in 2004, PAN has provided nearly 1 million under insured patients with over $3 billion in financial assistance, through close to 70 disease-specific programs.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Malcare WordPress Security